Publication | Closed Access

Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs

Viral PersistenceHepatologyViral HepatitisImmunologyHepatitis BHepatitisAntiviral TherapyAntiviral ResponseChronic Viral InfectionAdd-on Peg-interferon LeadsHbv DnaMedicineLong-term Nucleotide Analogs